Company intelligence / Profile preview

Possibility Neurotechnologies

Ownership: Private
Development stage: Commercial

Overview

Possibility Neurotechnologies has developed and launched the Think2Switch™ device—a plug-and-play brain-computer interface system that enables individuals with severe motor impairments to control real-world devices using their thoughts. The technology is designed for immediate use outside of research settings and has demonstrated practical benefits in children with quadriplegia, improving independence and quality of life[2][3][5][8].

Therapeutic areas: Neurology
Modalities: DeviceNon-pharmacological therapy
Industry: Assistive Medical Devices

Partnerships

Creative Destruction Lab Rockies program[3][7]Ontario Brain Institute NERVE program[9]

Beyond the preview

Go deeper on Possibility Neurotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Possibility Neurotechnologies.

Explore the full profile